instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'DOXORUBICIN'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | Intravesical | DrugAdministrationRoute | CC BY-NC | 33473244 | 18,858,074 | 2021 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | 50 ML DILUTED IN 100 CC OF SALINE | DrugDosageText | CC BY-NC | 33473244 | 18,846,152 | 2021 |
What was the outcome of reaction 'Dystrophic calcification'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | Recovered | ReactionOutcome | CC BY-NC | 33473244 | 18,858,074 | 2021 |
What was the outcome of reaction 'Extravasation of urine'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | Recovered | ReactionOutcome | CC BY-NC | 33473244 | 18,858,074 | 2021 |
What was the outcome of reaction 'Fat necrosis'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | Recovered | ReactionOutcome | CC BY-NC | 33473244 | 18,858,074 | 2021 |
What was the outcome of reaction 'Impaired healing'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | Recovered | ReactionOutcome | CC BY-NC | 33473244 | 18,858,074 | 2021 |
What was the outcome of reaction 'Micturition urgency'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | Recovered | ReactionOutcome | CC BY-NC | 33473244 | 18,858,074 | 2021 |
What was the outcome of reaction 'Pelvic pain'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | Recovering | ReactionOutcome | CC BY-NC | 33473244 | 18,870,263 | 2021 |
What was the outcome of reaction 'Perineal pain'? | Delayed Bladder Perforation Related to Immediate Single Dose Intravesical Doxorubicin Instillation After TURBT: A Case Report and Literature Review.
Intravesical chemotherapy instillation immediately after tumor resection is a well-known practice in the management of non-muscle invasive bladder cancer. Despite being la... | Recovering | ReactionOutcome | CC BY-NC | 33473244 | 18,870,263 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mediastinitis'. | Staphylococcus aureus mediastinitis due to subclavian vein perforation and catheter-related-infection.
In rare cases the implantation or use of a port-a-cath can be complicated by venous perforation or catheter-related infection. We describe a patient with these two complications resulting in Staphylococcus aureus medi... | PACLITAXEL, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33473350 | 18,991,130 | 2021 |
What was the administration route of drug 'PACLITAXEL'? | Staphylococcus aureus mediastinitis due to subclavian vein perforation and catheter-related-infection.
In rare cases the implantation or use of a port-a-cath can be complicated by venous perforation or catheter-related infection. We describe a patient with these two complications resulting in Staphylococcus aureus medi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33473350 | 18,991,130 | 2021 |
What was the administration route of drug 'PERTUZUMAB'? | Staphylococcus aureus mediastinitis due to subclavian vein perforation and catheter-related-infection.
In rare cases the implantation or use of a port-a-cath can be complicated by venous perforation or catheter-related infection. We describe a patient with these two complications resulting in Staphylococcus aureus medi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33473350 | 18,991,130 | 2021 |
What was the administration route of drug 'TRASTUZUMAB'? | Staphylococcus aureus mediastinitis due to subclavian vein perforation and catheter-related-infection.
In rare cases the implantation or use of a port-a-cath can be complicated by venous perforation or catheter-related infection. We describe a patient with these two complications resulting in Staphylococcus aureus medi... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33473350 | 18,991,130 | 2021 |
What was the outcome of reaction 'Mediastinitis'? | Staphylococcus aureus mediastinitis due to subclavian vein perforation and catheter-related-infection.
In rare cases the implantation or use of a port-a-cath can be complicated by venous perforation or catheter-related infection. We describe a patient with these two complications resulting in Staphylococcus aureus medi... | Recovered | ReactionOutcome | CC BY-NC-ND | 33473350 | 18,991,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain upper'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | IBUPROFEN, INDOMETHACIN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 18,863,279 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspirin-exacerbated respiratory disease'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | IBUPROFEN, INDOMETHACIN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 18,863,279 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthma'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | IBUPROFEN, INDOMETHACIN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 18,863,279 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchospasm'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | ACETAMINOPHEN\HYDROCODONE, ASPIRIN, IBUPROFEN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis allergic'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | IBUPROFEN, INDOMETHACIN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 18,863,279 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | IBUPROFEN, INDOMETHACIN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 18,863,279 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nasal congestion'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | ACETAMINOPHEN\HYDROCODONE, ASPIRIN, IBUPROFEN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Periorbital swelling'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | ACETAMINOPHEN\HYDROCODONE, ASPIRIN, IBUPROFEN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Type I hypersensitivity'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | IBUPROFEN, INDOMETHACIN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 18,863,279 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wheezing'. | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | ACETAMINOPHEN\HYDROCODONE, ASPIRIN, IBUPROFEN, MEFENAMIC ACID | DrugsGivenReaction | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
What was the dosage of drug 'ACETAMINOPHEN\HYDROCODONE'? | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | UNKNOWN | DrugDosageText | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
What was the dosage of drug 'ASPIRIN'? | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | UNKNOWN | DrugDosageText | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
What was the dosage of drug 'IBUPROFEN'? | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | UNKNOWN | DrugDosageText | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
What was the dosage of drug 'MEFENAMIC ACID'? | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | UNKNOWN | DrugDosageText | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
What was the outcome of reaction 'Urticaria'? | Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
OBJECTIVE
Data on non-steroidal anti-inflammatory drug (NSAID) hypersensitivity in Southeast Asia are scarce. Increased urinary leukotriene E4 (uLTE4) levels have been suggested... | Recovered | ReactionOutcome | CC BY-NC | 33474858 | 19,056,205 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | ACLIDINIUM BROMIDE, ALLOPURINOL, CEFOTAXIME SODIUM, FENTANYL, LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE, MIDAZOLAM, OXYGEN, PROPOFOL, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX SODIUM | DrugsGivenReaction | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | ACLIDINIUM BROMIDE, ALLOPURINOL, CEFOTAXIME SODIUM, FENTANYL, LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE, MIDAZOLAM, OXYGEN, PROPOFOL, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX SODIUM | DrugsGivenReaction | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | ACLIDINIUM BROMIDE, ALLOPURINOL, CEFOTAXIME SODIUM, FENTANYL, LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE, MIDAZOLAM, OXYGEN, PROPOFOL, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX SODIUM | DrugsGivenReaction | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
What is the weight of the patient? | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | 55 kg. | Weight | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
What was the administration route of drug 'CEFOTAXIME SODIUM'? | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
What was the administration route of drug 'MIDAZOLAM'? | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
What was the outcome of reaction 'Bradycardia'? | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | Recovered | ReactionOutcome | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
What was the outcome of reaction 'Cardiac arrest'? | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | Recovered | ReactionOutcome | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
What was the outcome of reaction 'Hypotension'? | Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.
Background and Objectives: Sugammadex is a modified γ-cyclodextrin largely used to prevent postoperative residual neuromuscular blockade induced by neuromuscular aminosteroid blocking agents. Although Sugammadex is consi... | Recovered | ReactionOutcome | CC BY | 33477765 | 20,168,163 | 2021-01-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Squamous cell carcinoma'. | Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp.
Immunotherapies directed at T-cell activation through antibodies targeting checkpoint proteins, such as programmed cell death 1 (PD1), are rapidly becoming the new standard of care in the treatme... | MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 33477979 | 19,099,795 | 2021-01-19 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp.
Immunotherapies directed at T-cell activation through antibodies targeting checkpoint proteins, such as programmed cell death 1 (PD1), are rapidly becoming the new standard of care in the treatme... | UNKNOWN | DrugDosageText | CC BY | 33477979 | 19,099,795 | 2021-01-19 |
What was the dosage of drug 'TACROLIMUS'? | Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp.
Immunotherapies directed at T-cell activation through antibodies targeting checkpoint proteins, such as programmed cell death 1 (PD1), are rapidly becoming the new standard of care in the treatme... | UNKNOWN | DrugDosageText | CC BY | 33477979 | 19,099,795 | 2021-01-19 |
What was the outcome of reaction 'Squamous cell carcinoma'? | Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp.
Immunotherapies directed at T-cell activation through antibodies targeting checkpoint proteins, such as programmed cell death 1 (PD1), are rapidly becoming the new standard of care in the treatme... | Recovering | ReactionOutcome | CC BY | 33477979 | 19,099,795 | 2021-01-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Embedded device'. | May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report.
BACKGROUND
Percutaneous Endoscopic Gastrostomy (PEG) can involve some complications, despite the good safety of its track record. The Buried Bumper Syndrome (BBS) is a rare, ... | CARBIDOPA\LEVODOPA | DrugsGivenReaction | CC BY | 33478385 | 18,959,148 | 2021-01-21 |
What was the administration route of drug 'CARBIDOPA\LEVODOPA'? | May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report.
BACKGROUND
Percutaneous Endoscopic Gastrostomy (PEG) can involve some complications, despite the good safety of its track record. The Buried Bumper Syndrome (BBS) is a rare, ... | Other | DrugAdministrationRoute | CC BY | 33478385 | 18,959,148 | 2021-01-21 |
What was the outcome of reaction 'Embedded device'? | May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report.
BACKGROUND
Percutaneous Endoscopic Gastrostomy (PEG) can involve some complications, despite the good safety of its track record. The Buried Bumper Syndrome (BBS) is a rare, ... | Recovered | ReactionOutcome | CC BY | 33478385 | 18,959,148 | 2021-01-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report.
BACKGROUND
Gastrointestinal lymphomas like diffuse large B-cell lymphoma (DLBCL) are rare complications of ulcerative colitis (UC), and only a few studies have repo... | BUDESONIDE, MESALAMINE | DrugsGivenReaction | CC BY | 33478454 | 18,941,161 | 2021-01-21 |
What was the administration route of drug 'BUDESONIDE'? | Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report.
BACKGROUND
Gastrointestinal lymphomas like diffuse large B-cell lymphoma (DLBCL) are rare complications of ulcerative colitis (UC), and only a few studies have repo... | Rectal | DrugAdministrationRoute | CC BY | 33478454 | 18,941,161 | 2021-01-21 |
What was the dosage of drug 'MESALAMINE'? | Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report.
BACKGROUND
Gastrointestinal lymphomas like diffuse large B-cell lymphoma (DLBCL) are rare complications of ulcerative colitis (UC), and only a few studies have repo... | MAINTENANCE THERAPY | DrugDosageText | CC BY | 33478454 | 18,941,161 | 2021-01-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | A 64-Year-Old Man with Low Back Pain Due to Clostridium perfringens Lumbar Discitis.
BACKGROUND Lumbar discitis caused by Clostridium perfringens is extremely rare. There have only been 7 published cases of confirmed discitis caused by Clostridium perfringens. We write this report to underscore this unusual relationshi... | ALLOPURINOL, CIPROFLOXACIN, LEVOTHYROXINE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33479190 | 18,868,938 | 2021-01-22 |
What is the weight of the patient? | A 64-Year-Old Man with Low Back Pain Due to Clostridium perfringens Lumbar Discitis.
BACKGROUND Lumbar discitis caused by Clostridium perfringens is extremely rare. There have only been 7 published cases of confirmed discitis caused by Clostridium perfringens. We write this report to underscore this unusual relationshi... | 140 kg. | Weight | CC BY-NC-ND | 33479190 | 18,868,938 | 2021-01-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS).
We retrospectively collected dat... | GLATIRAMER ACETATE | DrugsGivenReaction | CC BY-NC | 33480077 | 19,299,189 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coronavirus infection'. | Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS).
We retrospectively collected dat... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 33480077 | 17,774,031 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS).
We retrospectively collected dat... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 33480077 | 17,774,031 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Progressive multifocal leukoencephalopathy'. | Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS).
We retrospectively collected dat... | FINGOLIMOD | DrugsGivenReaction | CC BY-NC | 33480077 | 19,620,789 | 2021-04 |
What was the outcome of reaction 'COVID-19'? | Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS).
We retrospectively collected dat... | Fatal | ReactionOutcome | CC BY-NC | 33480077 | 19,299,189 | 2021-04 |
What was the outcome of reaction 'Coronavirus infection'? | Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS).
We retrospectively collected dat... | Fatal | ReactionOutcome | CC BY-NC | 33480077 | 17,774,031 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast cancer recurrent'. | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | ADO-TRASTUZUMAB EMTANSINE, CYCLOPHOSPHAMIDE, DOCETAXEL, ERIBULIN, LETROZOLE, PACLITAXEL, PERTUZUMAB, TRASTUZUMAB, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33482449 | 18,846,201 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Carbohydrate antigen 15-3 increased'. | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | ADO-TRASTUZUMAB EMTANSINE, CYCLOPHOSPHAMIDE, DOCETAXEL, ERIBULIN, LETROZOLE, PACLITAXEL, PERTUZUMAB, TRASTUZUMAB, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33482449 | 18,846,201 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to liver'. | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | ADO-TRASTUZUMAB EMTANSINE, CYCLOPHOSPHAMIDE, DOCETAXEL, ERIBULIN, LETROZOLE, PACLITAXEL, PERTUZUMAB, TRASTUZUMAB, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33482449 | 18,846,201 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | ADO-TRASTUZUMAB EMTANSINE, CYCLOPHOSPHAMIDE, DOCETAXEL, ERIBULIN, LETROZOLE, PACLITAXEL, PERTUZUMAB, TRASTUZUMAB, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33482449 | 18,846,201 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | ADO-TRASTUZUMAB EMTANSINE, CYCLOPHOSPHAMIDE, DOCETAXEL, EPIRUBICIN, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33482449 | 19,030,585 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | ADO-TRASTUZUMAB EMTANSINE, CYCLOPHOSPHAMIDE, DOCETAXEL, EPIRUBICIN, ERIBULIN, LETROZOLE, PACLITAXEL, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33482449 | 19,033,862 | 2021-02 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33482449 | 19,030,585 | 2021-02 |
What was the administration route of drug 'DOCETAXEL'? | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33482449 | 19,030,585 | 2021-02 |
What was the administration route of drug 'EPIRUBICIN'? | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33482449 | 19,030,585 | 2021-02 |
What was the administration route of drug 'PERTUZUMAB'? | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33482449 | 18,846,201 | 2021-02 |
What was the administration route of drug 'TRASTUZUMAB'? | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33482449 | 19,030,585 | 2021-02 |
What was the dosage of drug 'EPIRUBICIN HYDROCHLORIDE'? | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | 100 MG/M2, CYCLIC (FOUR TIMES EVERY 3 WEEKS) | DrugDosageText | CC BY | 33482449 | 18,991,560 | 2021-02 |
What was the dosage of drug 'VINORELBINE TARTRATE'? | Favorable survival with combined treatment in a metastatic breast cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Management of breast cancer patients undergoing hemodialysis (HD) is difficult because of a lack of evidence about drug selection, dose adjustment, and surgical procedures. We herein prese... | FOURTH?LINE TREATMENT, (VNR; 25 MG/M2 ON DAYS 1 AND 8 EVERY 3 WEEKS) | DrugDosageText | CC BY | 33482449 | 18,846,201 | 2021-02 |
What was the dosage of drug 'CYCLOSPORINE'? | Reconstruction using a frozen autograft for a skull and humeral lesion of synchronous multicentric osteosarcoma after undergoing successful neoadjuvant chemotherapy: a case report and review of the literature.
BACKGROUND
Synchronous multicentric osteosarcoma (SMOS) is a rare disease characterized by simultaneous multic... | EVERY THREE WEEKS | DrugDosageText | CC BY | 33482784 | 19,052,054 | 2021-01-22 |
What was the dosage of drug 'DOXORUBICIN'? | Reconstruction using a frozen autograft for a skull and humeral lesion of synchronous multicentric osteosarcoma after undergoing successful neoadjuvant chemotherapy: a case report and review of the literature.
BACKGROUND
Synchronous multicentric osteosarcoma (SMOS) is a rare disease characterized by simultaneous multic... | EVERY THREE WEEKS | DrugDosageText | CC BY | 33482784 | 19,052,054 | 2021-01-22 |
What was the dosage of drug 'ETOPOSIDE'? | Reconstruction using a frozen autograft for a skull and humeral lesion of synchronous multicentric osteosarcoma after undergoing successful neoadjuvant chemotherapy: a case report and review of the literature.
BACKGROUND
Synchronous multicentric osteosarcoma (SMOS) is a rare disease characterized by simultaneous multic... | EVERY THREE WEEKS | DrugDosageText | CC BY | 33482784 | 19,052,054 | 2021-01-22 |
What was the dosage of drug 'VINCRISTINE SULFATE'? | Reconstruction using a frozen autograft for a skull and humeral lesion of synchronous multicentric osteosarcoma after undergoing successful neoadjuvant chemotherapy: a case report and review of the literature.
BACKGROUND
Synchronous multicentric osteosarcoma (SMOS) is a rare disease characterized by simultaneous multic... | UNK (2 MG/BODY) | DrugDosageText | CC BY | 33482784 | 18,923,001 | 2021-01-22 |
What was the dosage of drug 'VINCRISTINE'? | Reconstruction using a frozen autograft for a skull and humeral lesion of synchronous multicentric osteosarcoma after undergoing successful neoadjuvant chemotherapy: a case report and review of the literature.
BACKGROUND
Synchronous multicentric osteosarcoma (SMOS) is a rare disease characterized by simultaneous multic... | EVERY THREE WEEKS | DrugDosageText | CC BY | 33482784 | 19,052,054 | 2021-01-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal insufficiency'. | A Case of Adrenal Insufficiency Diagnosed Using Optimal Dosing of Cosyntropin During Stimulation Testing.
BACKGROUND This case report illustrates the difficulties that arise during diagnosis of adrenal insufficiency, especially in the general medicine setting. Symptoms can often be nonspecific, and when a serum cortiso... | BUDESONIDE\FORMOTEROL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 33483462 | 18,927,415 | 2021-01-23 |
What was the dosage of drug 'BUDESONIDE\FORMOTEROL'? | A Case of Adrenal Insufficiency Diagnosed Using Optimal Dosing of Cosyntropin During Stimulation Testing.
BACKGROUND This case report illustrates the difficulties that arise during diagnosis of adrenal insufficiency, especially in the general medicine setting. Symptoms can often be nonspecific, and when a serum cortiso... | INHALER, UNK | DrugDosageText | CC BY-NC-ND | 33483462 | 18,927,415 | 2021-01-23 |
What was the dosage of drug 'TRIAMCINOLONE ACETONIDE'? | A Case of Adrenal Insufficiency Diagnosed Using Optimal Dosing of Cosyntropin During Stimulation Testing.
BACKGROUND This case report illustrates the difficulties that arise during diagnosis of adrenal insufficiency, especially in the general medicine setting. Symptoms can often be nonspecific, and when a serum cortiso... | UNK,TOPICAL SPRAY | DrugDosageText | CC BY-NC-ND | 33483462 | 18,927,415 | 2021-01-23 |
What was the outcome of reaction 'Adrenal insufficiency'? | A Case of Adrenal Insufficiency Diagnosed Using Optimal Dosing of Cosyntropin During Stimulation Testing.
BACKGROUND This case report illustrates the difficulties that arise during diagnosis of adrenal insufficiency, especially in the general medicine setting. Symptoms can often be nonspecific, and when a serum cortiso... | Recovering | ReactionOutcome | CC BY-NC-ND | 33483462 | 18,927,415 | 2021-01-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adenocarcinoma'. | Development of an optimal protocol for molecular profiling of tumor cells in pleural effusions at single-cell level.
Liquid biopsy analyzes the current status of primary tumors and their metastatic regions. We aimed to develop an optimized protocol for single-cell sequencing of floating tumor cells (FTCs) in pleural ef... | ATEZOLIZUMAB, BEVACIZUMAB, CARBOPLATIN, DOCETAXEL, GIMERACIL\OTERACIL\TEGAFUR, PEMETREXED DISODIUM | DrugsGivenReaction | CC BY-NC | 33484069 | 19,280,573 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oxygen saturation decreased'. | WALANT-Epinephrine injection may lead to short term, reversible episodes of critical oxygen saturation in the fingertips.
BACKGROUND
Although the WALANT technique's long-term safeness has been demonstrated in many studies, there are only few data investigating its short-term effects on tissue perfusion and oxygen level... | ARTICAINE, EPINEPHRINE | DrugsGivenReaction | CC BY | 33484301 | 19,715,987 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral ischaemia'. | WALANT-Epinephrine injection may lead to short term, reversible episodes of critical oxygen saturation in the fingertips.
BACKGROUND
Although the WALANT technique's long-term safeness has been demonstrated in many studies, there are only few data investigating its short-term effects on tissue perfusion and oxygen level... | ARTICAINE, EPINEPHRINE | DrugsGivenReaction | CC BY | 33484301 | 19,715,987 | 2021-03 |
What was the administration route of drug 'ARTICAINE'? | WALANT-Epinephrine injection may lead to short term, reversible episodes of critical oxygen saturation in the fingertips.
BACKGROUND
Although the WALANT technique's long-term safeness has been demonstrated in many studies, there are only few data investigating its short-term effects on tissue perfusion and oxygen level... | Subcutaneous | DrugAdministrationRoute | CC BY | 33484301 | 19,715,987 | 2021-03 |
What was the administration route of drug 'EPINEPHRINE'? | WALANT-Epinephrine injection may lead to short term, reversible episodes of critical oxygen saturation in the fingertips.
BACKGROUND
Although the WALANT technique's long-term safeness has been demonstrated in many studies, there are only few data investigating its short-term effects on tissue perfusion and oxygen level... | Subcutaneous | DrugAdministrationRoute | CC BY | 33484301 | 19,715,987 | 2021-03 |
What was the outcome of reaction 'Oxygen saturation decreased'? | WALANT-Epinephrine injection may lead to short term, reversible episodes of critical oxygen saturation in the fingertips.
BACKGROUND
Although the WALANT technique's long-term safeness has been demonstrated in many studies, there are only few data investigating its short-term effects on tissue perfusion and oxygen level... | Recovered | ReactionOutcome | CC BY | 33484301 | 19,715,987 | 2021-03 |
What was the outcome of reaction 'Peripheral ischaemia'? | WALANT-Epinephrine injection may lead to short term, reversible episodes of critical oxygen saturation in the fingertips.
BACKGROUND
Although the WALANT technique's long-term safeness has been demonstrated in many studies, there are only few data investigating its short-term effects on tissue perfusion and oxygen level... | Recovered | ReactionOutcome | CC BY | 33484301 | 19,715,987 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotonia neonatal'. | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | HUMAN C1-ESTERASE INHIBITOR | DrugsGivenReaction | CC BY | 33485376 | 18,845,589 | 2021-01-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | CHLOROPYRAMINE, HUMAN C1-ESTERASE INHIBITOR, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33485376 | 18,845,587 | 2021-01-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transient tachypnoea of the newborn'. | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | HUMAN C1-ESTERASE INHIBITOR | DrugsGivenReaction | CC BY | 33485376 | 18,845,589 | 2021-01-24 |
What was the administration route of drug 'CHLOROPYRAMINE'? | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33485376 | 18,845,587 | 2021-01-24 |
What was the dosage of drug 'CHLOROPYRAMINE'? | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | 20 MILLIGRAM | DrugDosageText | CC BY | 33485376 | 18,845,587 | 2021-01-24 |
What was the dosage of drug 'HUMAN C1-ESTERASE INHIBITOR'? | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | 2100 IU | DrugDosageText | CC BY | 33485376 | 18,845,587 | 2021-01-24 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | 160 MILLIGRAM | DrugDosageText | CC BY | 33485376 | 18,845,587 | 2021-01-24 |
What was the outcome of reaction 'Hypotonia neonatal'? | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | Recovered | ReactionOutcome | CC BY | 33485376 | 18,845,589 | 2021-01-24 |
What was the outcome of reaction 'Transient tachypnoea of the newborn'? | Successful treatment with Cinryze® replacement therapy of a pregnant patient with hereditary angioedema: a case report.
BACKGROUND
Hereditary angioedema (HAE) is a rare disease characterized with recurrent swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be presented with periphe... | Recovered | ReactionOutcome | CC BY | 33485376 | 18,845,589 | 2021-01-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'BK virus infection'. | Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease.
Viral infections are common complications following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Allo-HSCT recipients with steroid-refractory... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 33487167 | 18,939,834 | 2021-01-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic hepatitis'. | Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease.
Viral infections are common complications following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Allo-HSCT recipients with steroid-refractory... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 33487167 | 18,939,834 | 2021-01-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis E'. | Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease.
Viral infections are common complications following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Allo-HSCT recipients with steroid-refractory... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 33487167 | 18,939,834 | 2021-01-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Systemic mycosis'. | Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease.
Viral infections are common complications following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Allo-HSCT recipients with steroid-refractory... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 33487167 | 18,939,834 | 2021-01-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral infection'. | Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease.
Viral infections are common complications following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Allo-HSCT recipients with steroid-refractory... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 33487167 | 18,939,834 | 2021-01-24 |
What was the dosage of drug 'CYCLOSPORINE'? | Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease.
Viral infections are common complications following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Allo-HSCT recipients with steroid-refractory... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33487167 | 18,939,834 | 2021-01-24 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.